GOVERNMENT REPUBLIC SINGAPORE has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Brazil and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are WALLACH DAVID, VASGENE THERAPEUTICS INC and MADISON EDWIN L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Brazil | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Norway | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Bulgaria | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Chen Wei Ning | 11 |
#2 | Lim Gek Keow | 11 |
#3 | Leong Ai Lin | 10 |
#4 | Oon Chong Jin | 9 |
#5 | Zhao Yi | 7 |
#6 | Con Chong Jin | 2 |
#7 | Leong Ai-Lin | 1 |
#8 | Keow Lim Gek | 1 |
#9 | Chen Wei N | 1 |
#10 | Jin Oon Chong | 1 |
Publication | Filing date | Title |
---|---|---|
WO0018958A2 | An in vitro activity assay for human hepatits b virus (hbv) dna polymerase, the use of such an assay to assay activity of various serum samples and to screen for inhibitors of the hbv dna polymerase and a method of producing hbv dna polymerase | |
EP1086232A1 | A vaccine-induced hepatitis b viral strain and uses thereof |